SCHEMBL26133424

SCHEMBL26133424

COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(N)nc(F)nc43)C(C)(F)[C@@H]2OP(OCCC#N)N(C(C)C)C(C)C)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ TYMP P19971 2/20 0.37
▸ NT5E P21589 3/20 0.35
▸ ADORA1 P30542 5/20 0.31
▸ ADORA3 P0DMS8 3/20 0.31
▸ ADORA2A P29274 3/20 0.31
▸ ADORA2B P29275 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30141033 0.87 TYMP (0.42) TYMPNT5EADORA1
SCHEMBL30141043 0.87 TYMP (0.38) TYMPNT5EADORA1ADORA3ADORA2A
SCHEMBL31359555 0.87 TYMP (0.42) TYMPNT5EADORA1ADORA3ADORA2A
SCHEMBL30140968 0.84 TYMP (0.40) TYMPNT5EADORA1ADORA3ADORA2A
SCHEMBL30140974 0.84 TYMP (0.40) TYMPNT5EADORA1ADORA3ADORA2A
SCHEMBL31657632 0.84 TYMP (0.40) TYMP
SCHEMBL30091735 0.84 TYMP (0.40) TYMP
SCHEMBL31657586 0.83 TYMP (0.38) TYMPADORA3ADORA2AADORA2B
SCHEMBL30091740 0.83 TYMP (0.38) TYMPADORA3ADORA2AADORA2B
SCHEMBL30141086 0.81 TYMP (0.33) TYMPADORA1ADORA3ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250223588-A1 OLIGONUCLEOTIDES WITH 2'-DEOXY-2'-F-2'-C-METHYL NUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2025-07-10 — — US disclosed
EP-4419536-A1 OLIGONUCLEOTIDES WITH 2'-DEOXY-2'-F-2'-C-METHYL NUCLEOTIDES Alnylam Pharmaceuticals, Inc. (US) 2024-08-28 — — EP disclosed
WO-2023069495-A1 OLIGONUCLEOTIDES WITH 2'-DEOXY-2'-F-2'-C-METHYL NUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2023-04-27 — — WO disclosed
Send feedback